Hisamitsu Pharmaceutical completed the acquisition of partial assets related to S-Cup and Lacalut of Sanofi-backed SSP.

Hisamitsu Pharmaceutical completed the acquisition of partial assets related to S-Cup and Lacalut of Sanofi-backed SSP. Financial terms were not disclosed. In the future, Hisamitsu is committed to maximizing the values of S-Cup and Lacalut transferred from SSP as well as offering a variety of products and services not limited to patches, and developing a wide range of business operations.